A detailed history of Sawyer & Company, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Sawyer & Company, Inc holds 57,691 shares of NVO stock, worth $5.08 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares
57,691
Holding current value
$5.08 Million
% of portfolio
1.84%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$85.0 - $120.04 $4.9 Million - $6.93 Million
57,691 New
57,691 $4.96 Million
Q1 2019

May 06, 2019

SELL
$46.36 - $52.63 $3,013 - $3,420
-65 Closed
0 $0
Q4 2017

Jan 11, 2018

BUY
$47.53 - $53.73 $3,089 - $3,492
65
65 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sawyer & Company, Inc Portfolio

Follow Sawyer & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.